These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

452 related items for PubMed ID: 16013087

  • 1. A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: implications for cellular magnetic resonance imaging.
    Arbab AS, Wilson LB, Ashari P, Jordan EK, Lewis BK, Frank JA.
    NMR Biomed; 2005 Oct; 18(6):383-9. PubMed ID: 16013087
    [Abstract] [Full Text] [Related]

  • 2. Transferrin receptor upregulation: in vitro labeling of rat mesenchymal stem cells with superparamagnetic iron oxide.
    Schäfer R, Kehlbach R, Wiskirchen J, Bantleon R, Pintaske J, Brehm BR, Gerber A, Wolburg H, Claussen CD, Northoff H.
    Radiology; 2007 Aug; 244(2):514-23. PubMed ID: 17562811
    [Abstract] [Full Text] [Related]

  • 3. [Labeling of mesenchymal stem cells with different superparamagnetic particles of iron oxide and detectability with MRI at 3T].
    Ittrich H, Lange C, Dahnke H, Zander AR, Adam G, Nolte-Ernsting C.
    Rofo; 2005 Aug; 177(8):1151-63. PubMed ID: 16021549
    [Abstract] [Full Text] [Related]

  • 4. Physical and biological characterization of superparamagnetic iron oxide- and ultrasmall superparamagnetic iron oxide-labeled cells: a comparison.
    Sun R, Dittrich J, Le-Huu M, Mueller MM, Bedke J, Kartenbeck J, Lehmann WD, Krueger R, Bock M, Huss R, Seliger C, Gröne HJ, Misselwitz B, Semmler W, Kiessling F.
    Invest Radiol; 2005 Aug; 40(8):504-13. PubMed ID: 16024988
    [Abstract] [Full Text] [Related]

  • 5. Cellular uptake and trafficking of a prototypical magnetic iron oxide label in vitro.
    Schulze E, Ferrucci JT, Poss K, Lapointe L, Bogdanova A, Weissleder R.
    Invest Radiol; 1995 Oct; 30(10):604-10. PubMed ID: 8557500
    [Abstract] [Full Text] [Related]

  • 6. Intracytoplasmic tagging of cells with ferumoxides and transfection agent for cellular magnetic resonance imaging after cell transplantation: methods and techniques.
    Arbab AS, Bashaw LA, Miller BR, Jordan EK, Bulte JW, Frank JA.
    Transplantation; 2003 Oct 15; 76(7):1123-30. PubMed ID: 14557764
    [Abstract] [Full Text] [Related]

  • 7. Preparation and quality test of superparamagnetic iron oxide labeled antisense oligodeoxynucleotide probe: a preliminary study.
    Wen M, Li B, Ouyang Y, Luo Y, Li S.
    Ann Biomed Eng; 2009 Jun 15; 37(6):1240-50. PubMed ID: 19337837
    [Abstract] [Full Text] [Related]

  • 8. The pharmacokinetics of the lymphotropic nanoparticle MRI contrast agent ferumoxtran-10.
    Islam T, Wolf G.
    Cancer Biomark; 2009 Jun 15; 5(2):69-73. PubMed ID: 19414923
    [Abstract] [Full Text] [Related]

  • 9. Labeling of human mesenchymal stromal cells with superparamagnetic iron oxide leads to a decrease in migration capacity and colony formation ability.
    Schäfer R, Kehlbach R, Müller M, Bantleon R, Kluba T, Ayturan M, Siegel G, Wolburg H, Northoff H, Dietz K, Claussen CD, Wiskirchen J.
    Cytotherapy; 2009 Jun 15; 11(1):68-78. PubMed ID: 19191056
    [Abstract] [Full Text] [Related]

  • 10. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents.
    Frank JA, Miller BR, Arbab AS, Zywicke HA, Jordan EK, Lewis BK, Bryant LH, Bulte JW.
    Radiology; 2003 Aug 15; 228(2):480-7. PubMed ID: 12819345
    [Abstract] [Full Text] [Related]

  • 11. Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10.
    Raynal I, Prigent P, Peyramaure S, Najid A, Rebuzzi C, Corot C.
    Invest Radiol; 2004 Jan 15; 39(1):56-63. PubMed ID: 14701989
    [Abstract] [Full Text] [Related]

  • 12. Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging.
    Arbab AS, Bashaw LA, Miller BR, Jordan EK, Lewis BK, Kalish H, Frank JA.
    Radiology; 2003 Dec 15; 229(3):838-46. PubMed ID: 14657318
    [Abstract] [Full Text] [Related]

  • 13. [A preparation technique for quantitative investigation of SPIO-containing solutions and SPIO-labelled cells by MRI].
    Pintaske J, Helms G, Bantleon R, Kehlbach R, Wiskirchen J, Claussen CD, Schick F.
    Biomed Tech (Berl); 2005 Jun 15; 50(6):174-80. PubMed ID: 16003918
    [Abstract] [Full Text] [Related]

  • 14. Cell tagging with clinically approved iron oxides: feasibility and effect of lipofection, particle size, and surface coating on labeling efficiency.
    Matuszewski L, Persigehl T, Wall A, Schwindt W, Tombach B, Fobker M, Poremba C, Ebert W, Heindel W, Bremer C.
    Radiology; 2005 Apr 15; 235(1):155-61. PubMed ID: 15749976
    [Abstract] [Full Text] [Related]

  • 15. Magnetic labeling of non-phagocytic adherent cells with iron oxide nanoparticles: a comprehensive study.
    Boutry S, Brunin S, Mahieu I, Laurent S, Vander Elst L, Muller RN.
    Contrast Media Mol Imaging; 2008 Apr 15; 3(6):223-32. PubMed ID: 19072771
    [Abstract] [Full Text] [Related]

  • 16. Hepatic cellular distribution and degradation of iron oxide nanoparticles following single intravenous injection in rats: implications for magnetic resonance imaging.
    Briley-Saebo K, Bjørnerud A, Grant D, Ahlstrom H, Berg T, Kindberg GM.
    Cell Tissue Res; 2004 Jun 15; 316(3):315-23. PubMed ID: 15103550
    [Abstract] [Full Text] [Related]

  • 17. Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro.
    Metz S, Bonaterra G, Rudelius M, Settles M, Rummeny EJ, Daldrup-Link HE.
    Eur Radiol; 2004 Oct 15; 14(10):1851-8. PubMed ID: 15249981
    [Abstract] [Full Text] [Related]

  • 18. Heparin-coated superparamagnetic iron oxide for in vivo MR imaging of human MSCs.
    Lee JH, Jung MJ, Hwang YH, Lee YJ, Lee S, Lee DY, Shin H.
    Biomaterials; 2012 Jun 15; 33(19):4861-71. PubMed ID: 22475532
    [Abstract] [Full Text] [Related]

  • 19. Superparamagnetic iron oxide nanoparticle-labeled cells as an effective vehicle for tracking the GFP gene marker using magnetic resonance imaging.
    Zhang Z, Mascheri N, Dharmakumar R, Fan Z, Paunesku T, Woloschak G, Li D.
    Cytotherapy; 2009 Jun 15; 11(1):43-51. PubMed ID: 18956269
    [Abstract] [Full Text] [Related]

  • 20. Detection of viability of transplanted beta cells labeled with a novel contrast agent - polyvinylpyrrolidone-coated superparamagnetic iron oxide nanoparticles by magnetic resonance imaging.
    Zhang B, Jiang B, Chen Y, Huang H, Xie Q, Kang M, Zhang H, Zhai C, Wu Y.
    Contrast Media Mol Imaging; 2012 Jun 15; 7(1):35-44. PubMed ID: 22344878
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.